Subscribe to our Newsletters !!

    Kumar Jeetendra

    EMA opens audit of China’s Sinovac Covid jab

    The European Medicines Agency said Tuesday it has started a “rolling review” of China’s Sinovac coronavirus jab, a process that could lead to eventual approval for the European market. Made by Sinovac’s Beijing-based Life Sciences unit, the vaccine contains an inactivated coronavirus that cannot cause a disease, but helps a person to develop antibodies against

    Take a look at blood with analysis machines

    High-tech machines analyze human blood samples, detect coagulation disorders and thus help to save lives. The maxon sales company in France does not only supply the appropriate drives – in fact, it builds entire conveyor modules. A peek inside. Our blood is a fascinating fluid. It transports oxygen and nutrients, fends off foreign objects and

    Advent Chembio announces the launch of Pharmacopeial labelled solvents

    Advent Chembio Pvt ltd is a Mumbai based Chemicals Manufacturing Company and aspires to be a leading supplier of Analytical reagents, Fine & Specialty chemicals, Customized intermediates, and a trusted partner in quality to meet the growing developmental and manufacturing needs of various sectors in Chemical, Pharmaceutical, and allied industries. The company announces the launch

    Roche receives Emergency Use Authorisation in India for its investigational Antibody Cocktail used in the treatment of Covid-19

    Roche receives Emergency Use Authorisation in India for its investigational Antibody Cocktail (Casirivimab and Imdevimab) used in the treatment of Covid-19 Casirivimab and Imdevimab is indicated for the treatment of mild to moderate Covid-19 in high-risk patients Partners with Cipla for pan-India distribution At a global level, Roche and its partner Regeneron are collaborating to

    Colloidal Nanoparticles Advance Frontiers of Synthetic Chemistry

    Researchers from the School of Chemistry at the University of St Andrews (UK) are using a DrySyn Spiral Evaporator from Asynt to help synthesize novel reactive colloidal nanoparticles that present an exciting tool to create a new generation of ‘smart’ nanomaterials. The unique properties of nanomaterials mean that potential applications extend from use in smart

    Takara Bio Europe AB and PanCryos Announce Licensing Agreement to Enable Development of Cell-Based Therapy for Diabetes

    Göteberg, Sweden – May 05, 2021 – Life Science Newswire – Takara Bio Europe AB (TBEAB) and PanCryos are pleased to announce that they have reached a licensing agreement surrounding TBEAB’s clinical-grade human embryonic stem (hES) cell lines. PanCryos has established a simplified and effective method to generate stem cell-derived, glucose-responsive beta cells and is

    NEC contributes to development of artificial DNA aptamer that binds to the novel coronavirus (SARS-CoV-2)

    India, May 6, 2021 – NEC Corporation (NEC; TSE: 6701) and NEC Solution Innovators today announced the successful development of artificial DNA aptamers (*1) that bind to the novel coronavirus (SARS-CoV-2). This breakthrough stems from the NEC Group’s efforts to promote spatial monitoring business using aptamers, including the development of new biosensing systems, such as

    DRDO Centre for Artificial Intelligence and Robotics, with the support of 5C Network & HCG Academics develops ‘Atman AI’ for COVID detection in Chest X-rays

    Bangalore 7th May 2021: DRDO Centre for Artificial Intelligence and Robotics, with the support of 5C Network & HCG Academics has developed “ATMAN AI”, an Artificial Intelligence algorithm that can detect the presence of COVID-19 disease in Chest X Rays. The ATMAN AI is an artificial intelligence tool for Chest X-ray screening as triaging tool